US34385P1084 - Common Stock
STANDARD BIOTOOLS INC
NASDAQ:LAB (9/18/2024, 8:12:14 PM)
After market: 2.03 0 (0%)2.03
+0.03 (+1.5%)
Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. The company is headquartered in South San Francisco, California and currently employs 534 full-time employees. The company went IPO on 2011-02-10. The firm's segments include Proteomics and Genomics. The Proteomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of genes and their functions. The firm provides insights in health and disease using its mass cytometry and microfluidics technologies, which serve applications in proteomics and genomic. The company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories around the world, focusing on the needs in translational and clinical research, including oncology, immunology, and immunotherapy. The firm also provides differentiated multi-omics tools for research.
STANDARD BIOTOOLS INC
2 Tower Place, Suite 2000
South San Francisco CALIFORNIA
P: 16502666000
Employees: 534
Website: https://www.standardbio.com/
Standard BioTools to Participate in Upcoming Investor Conferences...
Standard BioTools just reported results for the second quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Standard BioTools (NASDAQ:LAB) just reported results for the second quarter of ...
Standard BioTools Announces Senior Leadership Changes...
Standard BioTools Reports Second Quarter 2024 Financial Results...
Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024...
Here you can normally see the latest stock twits on LAB, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: